AdaptHealth Corp.

NASDAQ:AHCO

Medical - Devices

Healthcare
$7.37 +0.10%

+$0.01 today

Market cap
$1.01B
Beta
1.46
P/E (TTM)
-16.3
EPS (TTM)
-$0.59
52W Low $8.06High $13.43

Volume 1.54M

Average 1.38M

AHCO Interest Expense

Cost of servicing the company's debt during the period.

AdaptHealth Corp.NASDAQ: AHCO

Interest Expense · Q1 FY2026 · quarter ended Apr 2026

Interest expense declines year over year

Q1 FY2026 interest expense of $25.59M fell 9.9% year over year, ahead of the -16.0% change in trailing-twelve-month interest expense. Sequentially, it rose 4.7% from the prior quarter. Over 3 fiscal years it compounded at -1.1% a year.

Context

  • Interest expense amounted to 3.3% of revenue in FY2025, down 0.6 pp from a year earlier.
  • Interest expense increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -9.9% holds above the trailing-twelve-month pace of -16.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterApr 2026
$25.59M+4.7% QoQ
Last fiscal yearDec 2025
$105.75M-16.5% YoY
LTMApr 2026
$102.95M-16.0% YoY
Interest Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-9.9%——
1 year-16.5%——
3-year CAGR-1.1%——
5-year CAGR——
10-year CAGR——

Interest Expense history

USD · from the income statement

Latest · FY2025
105.75M USD
Year-over-year change
-16.5%
4-year CAGR
+2.7%

Interest Expense vs competitors

How AHCO compares with its peers on the latest reported figures

  • AHCO's LTM Apr 2026 interest expense of $102.95M is the highest of the 9 companies compared; the peer median is $486.5K.
  • Its year-over-year change of -16.0% is the 5th highest of 6, against a peer median of +62.5%.
  • Interest expense amounts to 3.6% of revenue for AHCO, versus a peer median of 0.2%.
AHCO Competitors Peer median
Interest Expense for AHCO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AHCOAdaptHealth Corp.LTM Apr 2026$102.95M -16.0%-1.1%3.6%
RMDResMed Inc.LTM Jun 2026$29.03M +115.5%—0.5%
TNDMTandem Diabetes Care, Inc.LTM Mar 2026$8.31M +20.8%+8.4%0.8%
VMDViemed Healthcare, Inc.LTM Mar 2026$1.31M +62.5%+81.7%0.5%
INFUInfuSystem Holdings, Inc.LTM Mar 2026$840K -49.3%-2.5%0.6%
INSPInspire Medical Systems, Inc.LTM Jun 2026$133K +411.5%-56.6%0.0%
BBNXBeta Bionics, Inc.LTM Mar 2026$0 ——0.0%
ELMDElectromed, Inc.LTM Mar 2026$0 ——0.0%
INGNInogen, Inc.LTM Mar 2026$0 ——0.0%
Peer median (excluding AHCO) $486.5K+62.5%+2.9%0.2%

Competitors are the stored peer set for AHCO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.45B2.97B3.2B3.26B3.24B
Cost of Revenue2.01B2.55B2.52B2.58B2.68B
Gross Profit445.61M417.43M681.77M681.09M568.56M
Gross Margin18.2%14.1%21.3%20.9%17.5%
Research & Development00000
Selling, General & Admin167.51M162.13M190.09M359.24M382.29M
Operating Expenses220.01M227.02M1.28B417.36M382.29M
Depreciation & Amortization258.05M423.44M420.59M365.33M413.04M
EBITDA544.21M630.76M(171.09M)628.02M503.64M
EBITDA Margin22.2%21.2%-5.3%19.3%15.5%
Operating Income225.61M190.41M(598.4M)263.73M186.27M
Operating Margin9.2%6.4%-18.7%8.1%5.7%
Interest Income00000
Interest Expense95.2M109.41M130.3M126.67M105.75M
Other Income / Expenses(34.65M)(92.51M)(125.38M)(127.71M)(201.42M)
Income Before Tax190.96M97.9M(723.78M)136.02M(15.15M)
Pre-Tax Margin7.8%3.3%-22.6%4.2%-0.5%
Income Tax Expense32.81M24.77M(49M)41.24M50.88M
Net Income156.18M69.32M(678.9M)90.42M(70.79M)
Net Margin6.4%2.3%-21.2%2.8%-2.2%
EPS (Basic)1.120.52(5.32)0.62(0.52)
EPS (Diluted)0.670.50(5.31)0.61(0.52)
Weighted Avg Shares126.31M134.18M134.16M133.76M135.15M
Weighted Avg Shares (Diluted)133.03M138.99M134.42M135.53M135.15M

AdaptHealth Corp.

NASDAQ:AHCO

Intrinsic Alpha fair value

Locked

Current Price

$7.37

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.